Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for accucaps industries in registrations and monthly communication reports

Refine monthly communication reports results by

Type
Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (55)
Results: 1-50 | Export
  1. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: Jeff Watson, President and COO
    Registration: 28 of 29 (2018-01-26 to 2019-01-13)
    Posted: 2018-06-06
    Subject matter details: 6
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  2. Apotex Inc.
    Type: Consultant
    Lobbyist: JEFF SMITH, Drysdale Forstner Hamilton Public Affairs
    Registration: 1 of 1 (2017-08-22 to 2018-01-01)
    Posted: 2017-08-22
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  3. Apotex Inc.
    Type: Consultant
    Lobbyist: Bruce Drysdale, Drysdale Forstner Hamilton Public Affairs
    Registration: 1 of 1 (2017-08-22 to 2017-12-31)
    Posted: 2017-08-22
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  4. Apotex Inc.
    Type: Consultant
    Lobbyist: Jasmine Igneski, DFH Public Affairs
    Registration: 1 of 1 (2017-08-17 to 2017-12-31)
    Posted: 2017-08-18
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  5. Apotex Inc.
    Type: Consultant
    Lobbyist: Calvin Goldman, Goodmans LLP
    Registration: 4 of 4 (2016-12-22 to 2018-03-22)
    Posted: 2016-12-29
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  6. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 11 of 11 (2016-12-22 to 2017-10-24)
    Posted: 2016-12-29
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  7. Apotex Inc.
    Type: Consultant
    Lobbyist: Andrew Steele, StrategyCorp Inc.
    Registration: 2 of 2 (2016-11-14 to 2016-12-31)
    Posted: 2016-12-15
    Subject matter details: 5
    Government institutions: 8
    Communication techniques: 3
    Government funding: No
  8. Apotex Inc.
    Type: Consultant
    Lobbyist: Andrew Steele, StrategyCorp Inc.
    Registration: 1 of 2 (2016-09-26 to 2016-11-14)
    Posted: 2016-09-29
    Subject matter details: 5
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
  9. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: Jeremy Desai, President and CEO
    Registration: 27 of 29 (2016-04-21 to 2017-05-16)
    Posted: 2016-04-21
    Subject matter details: 6
    Government institutions: 17
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  10. Apotex Inc.
    Type: Consultant
    Lobbyist: JOHN DUFFY, StrategyCorp Inc.
    Registration: 4 of 4 (2016-04-15 to 2016-12-31)
    Posted: 2016-06-13
    Subject matter details: 5
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
  11. Apotex Inc.
    Type: Consultant
    Lobbyist: Brian Teefy, StrategyCorp Inc.
    Registration: 1 of 2 (2016-03-16 to 2016-03-16)
    Posted: 2016-03-21
    Subject matter details: 5
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  12. Apotex Inc.
    Type: Consultant
    Lobbyist: Brian Teefy, StrategyCorp Inc.
    Registration: 2 of 2 (2016-03-16 to 2016-12-31)
    Posted: 2016-03-24
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  13. Apotex Inc.
    Type: Consultant
    Lobbyist: JOHN DUFFY, StrategyCorp Inc.
    Registration: 3 of 4 (2016-03-09 to 2016-04-15)
    Posted: 2016-04-14
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  14. APOTEX INC.
    Type: Consultant
    Lobbyist: Danya Vered, StrategyCorp Inc
    Registration: 1 of 2 (2016-03-02 to 2016-03-02)
    Posted: 2016-03-13
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  15. APOTEX INC.
    Type: Consultant
    Lobbyist: Danya Vered, StrategyCorp Inc
    Registration: 2 of 2 (2016-03-02 to 2016-12-31)
    Posted: 2016-04-18
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  16. Apotex Inc.
    Type: Consultant
    Lobbyist: JOHN DUFFY, StrategyCorp Inc.
    Registration: 1 of 4 (2016-03-01 to 2016-03-01)
    Posted: 2016-03-13
    Subject matter details: 5
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  17. Apotex Inc.
    Type: Consultant
    Lobbyist: JOHN DUFFY, StrategyCorp Inc.
    Registration: 2 of 4 (2016-03-01 to 2016-03-09)
    Posted: 2016-03-24
    Subject matter details: 5
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  18. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 10 of 11 (2016-01-20 to 2016-12-22)
    Posted: 2016-01-20
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  19. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: Jeremy Desai, President and CEO
    Registration: 26 of 29 (2015-11-16 to 2016-04-21)
    Posted: 2015-11-16
    Subject matter details: 6
    Government institutions: 17
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  20. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: Jeremy Desai, President and CEO
    Registration: 25 of 29 (2015-07-02 to 2015-11-16)
    Posted: 2015-07-02
    Subject matter details: 6
    Government institutions: 16
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  21. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 9 of 11 (2015-04-16 to 2016-01-20)
    Posted: 2015-04-21
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  22. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 8 of 11 (2014-12-18 to 2015-04-16)
    Posted: 2014-12-18
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  23. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 7 of 11 (2014-08-19 to 2014-12-18)
    Posted: 2014-08-20
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  24. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: Jeremy Desai, President and CEO
    Registration: 24 of 29 (2014-08-01 to 2015-07-02)
    Posted: 2014-12-18
    Subject matter details: 6
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  25. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 6 of 11 (2014-04-25 to 2014-08-19)
    Posted: 2014-04-28
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  26. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, CEO
    Registration: 23 of 29 (2014-02-19 to 2014-08-01)
    Posted: 2014-02-19
    Subject matter details: 6
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  27. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 5 of 11 (2013-12-18 to 2014-04-25)
    Posted: 2013-12-18
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  28. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, CEO
    Registration: 22 of 29 (2013-11-26 to 2014-02-19)
    Posted: 2013-11-26
    Subject matter details: 6
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  29. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, CEO
    Registration: 21 of 29 (2013-10-23 to 2013-11-26)
    Posted: 2013-10-24
    Subject matter details: 6
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  30. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 4 of 11 (2013-08-16 to 2013-12-18)
    Posted: 2013-08-22
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  31. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 3 of 11 (2013-04-18 to 2013-08-16)
    Posted: 2013-04-18
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  32. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, CEO
    Registration: 20 of 29 (2012-12-12 to 2013-10-23)
    Posted: 2012-12-12
    Subject matter details: 6
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  33. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 2 of 11 (2012-12-05 to 2013-04-18)
    Posted: 2012-12-05
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  34. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 19 of 29 (2012-04-02 to 2012-12-12)
    Posted: 2012-04-02
    Subject matter details: 6
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  35. Apotex
    Type: Consultant
    Lobbyist: Harry Radomski, Goodmans LLP
    Registration: 1 of 11 (2012-01-12 to 2012-12-05)
    Posted: 2012-02-21
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  36. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 18 of 29 (2011-11-22 to 2012-04-02)
    Posted: 2011-12-20
    Subject matter details: 6
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  37. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 17 of 29 (2011-08-14 to 2011-11-22)
    Posted: 2011-10-21
    Subject matter details: 5
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  38. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 16 of 29 (2010-09-02 to 2011-03-02)
    Posted: 2010-09-03
    Subject matter details: 5
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  39. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 15 of 29 (2009-01-23 to 2010-09-02)
    Posted: 2010-05-25
    Subject matter details: 5
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  40. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 14 of 29 (2008-01-16 to 2009-01-23)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 10
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 2
  41. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 13 of 29 (2007-07-16 to 2008-01-16)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 10
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 2
  42. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 12 of 29 (2007-01-19 to 2007-07-16)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 5
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 2
  43. Apotex Inc.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 11 of 29 (2005-09-07 to 2007-07-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 6
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
    Employees who lobby: 2
  44. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: ELIE BETITO, DIRECTOR OF PUBLIC & GOVERNMENT AFFAIRS
    Registration: 10 of 10 (2005-03-11 to 2005-06-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  45. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: ELIE BETITO, DIRECTOR OF PUBLIC & GOVERNMENT AFFAIRS
    Registration: 9 of 10 (2004-02-05 to 2005-03-09)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  46. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 9 of 29 (2004-02-05 to 2005-03-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 12
    Communication techniques: 6
    Government funding: No
  47. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: BARRY SHERMAN, CHAIRMAN & CEO
    Registration: 9 of 10 (2004-02-05 to 2005-03-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  48. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: JACK KAY, PRESIDENT & COO
    Registration: 8 of 29 (2003-02-25 to 2004-02-05)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 12
    Communication techniques: 6
    Government funding: No
  49. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: ELIE BETITO, DIRECTOR OF PUBLIC & GOVERNMENT AFFAIRS
    Registration: 8 of 10 (2003-02-25 to 2004-02-04)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  50. APOTEX INC.
    Type: In-house Corporation
    Responsible officer: BARRY SHERMAN, CHAIRMAN & CEO
    Registration: 8 of 10 (2003-02-25 to 2004-02-05)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
Date Modified: